Neos Investment Management LLC Ascendis Pharma A/S Transaction History
Neos Investment Management LLC
- $3.31 Trillion
- Q3 2024
A detailed history of Neos Investment Management LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Neos Investment Management LLC holds 13,304 shares of ASND stock, worth $1.85 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
13,304
Previous 10,837
22.76%
Holding current value
$1.85 Million
Previous $1.48 Billion
34.4%
% of portfolio
0.06%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding ASND
# of Institutions
244Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.35 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$713 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$692 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$612 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$581 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.75B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...